Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Autoimmune Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07000292
What this trial is testing

MSC303 Subcutaneous Injection for the Treatment of Immunologic Glomerular Disease.

Who this might be right for
Lupus Nephritis (LN)ANCA-Associated Glomerulonephritis
Shanghai Changzheng Hospital 12
Not applicableActive Not RecruitingNCT07020936
What this trial is testing

AIDANET Pediatrics

Who this might be right for
Type 1 Diabetes
Mark D. DeBoer, MD, MSc., MCR 42
Testing effectiveness (Phase 2)Study completedNCT01031836
What this trial is testing

Evaluate Safety and Tolerability of IV or SC Dose of MEDI-545 in Patients With Systemic Lupus Erythematosus.

Who this might be right for
Systemic Lupus Erythematosus
AstraZeneca 30
Not applicableStudy completedNCT04411407
What this trial is testing

PROM Collected Via a WebApp Versus a Touch Screen Solution Among Patients With SLE

Who this might be right for
Systemic Lupus Erythematosus
Salome Kristensen 34
Early research (Phase 1)Study completedNCT04276207
What this trial is testing

LY900014 Versus Insulin Lispro (Humalog) on High Blood Sugar in Participants With Type 1 Diabetes Who Use Insulin Pumps

Who this might be right for
Diabetes Mellitus, Type 1
Eli Lilly and Company 32
Post-approval studies (Phase 4)Study completedNCT02410278
What this trial is testing

Study of Montelukast on Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera

Who this might be right for
Multiple Sclerosis
Biogen 102
Testing effectiveness (Phase 2)Study completedNCT00618085
What this trial is testing

Motor Imagery Practice in Neurological Rehabilitation

Who this might be right for
StrokeBrain InjuryMultiple Sclerosis
Nuffield Orthopaedic Centre NHS Trust 50
Not applicableWithdrawnNCT01973517
What this trial is testing

High-Field MRI Iron-Based Contrast-Enhanced Characterization of Multiple Sclerosis and Demyelinating Diseases

Who this might be right for
Multiple Sclerosis
Stanford University
Not applicableStudy completedNCT06428591
What this trial is testing

Tandem Freedom Feasibility Study 1

Who this might be right for
Diabetes Mellitus, Type 1
Tandem Diabetes Care, Inc. 10
Not applicableStudy completedNCT02144935
What this trial is testing

Collaborative Assessment of Pediatric Transverse Myelitis: Understand, Reveal, Educate or CAPTURE Study

Who this might be right for
Myelitis, TransverseFlaccid Paraplegia, Complete, AcuteFlaccid Paraplegia, Incomplete, Acute
University of Texas Southwestern Medical Center 106
Not applicableStudy completedNCT03737825
What this trial is testing

Computerized Cognitive Training in MS

Who this might be right for
Multiple SclerosisCognitive Decline
University of California, San Francisco 2
Not applicableStudy completedNCT04196140
What this trial is testing

Pivotal Omnipod Horizon™ Automated Glucose Control System

Who this might be right for
Type 1 Diabetes Mellitus
Insulet Corporation 240
Large-scale testing (Phase 3)Not Yet RecruitingNCT07642050
What this trial is testing

Determine if BHV-1400 is Effective and Safe in Adults With IgA Nephropathy

Who this might be right for
IgA Nephropathy
Biohaven Therapeutics Ltd. 420
Large-scale testing (Phase 3)Study completedNCT02525874
What this trial is testing

Effect of BG00012 on Lymphocyte Subsets and Immunoglobulins in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS).

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis
Biogen 218
Not applicableStudy completedNCT05951985
What this trial is testing

High Intensity Functional Training for Individuals With Neurologic Diagnoses and Their Care Partners

Who this might be right for
Neurologic DisorderParkinson DiseaseSpinal Cord Injuries+5 more
Arkansas Colleges of Health Education 100
Post-approval studies (Phase 4)Study completedNCT01638715
What this trial is testing

A Randomized, Multi-Center Biomarker Trial to Predict Therapeutic Responses of Patients With Rheumatoid Arthritis to a Specific Biologic Mode of Action

Who this might be right for
Rheumatoid Arthritis
Medical University of Vienna 115
Large-scale testing (Phase 3)Study completedNCT01213017
What this trial is testing

The Effect of Certolizumab Pegol on MRI Synovitis and Bone Edema in Rheumatoid Arthritis Patients

Who this might be right for
Rheumatoid Arthritis
Oklahoma Medical Research Foundation 20
Not applicableUnknownNCT04073940
What this trial is testing

Exploration of Brain Changes Due to a Targeted Ballet Program in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
University of Illinois at Urbana-Champaign 30
Post-approval studies (Phase 4)UnknownNCT02325440
What this trial is testing

Study to Assess Immune Function and MRI Disease Activity in RRMS Patients When Switching From Natalizumab to Gilenya

Who this might be right for
Relapsing Remitting Multiple Sclerosis
University Hospital Muenster 15
Not applicableStudy completedNCT03743740
What this trial is testing

The Effect of Spinal Stabilization Exercises in Patients With Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
Hacettepe University 10
Next Page